// App-Quantinova.ai

: Timing and Frequency of Cardiopulmonary Testing in Persons with Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • C. Holtze

Principal Investigators

  • C. R. Cooke

  • M. L. Salisbury

  • B. Wang

  • J. S. Sheth

  • E. Belloli

  • E. S. White

  • K. R. Flaherty

Medical Centers

  • Internal Medicine, The University of Michigan, Ann Arbor, MI, United States

  • The University of Michigan, Ann Arbor, Michigan, United States

  • Pulmonary and Critical Care, Ann Arbor, MI, United States,

  • Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, United States

  • The University of Michigan, Ann Arbor, Michigan, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Pneumothorax

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A